Dr. Reddy's Laboratories is voluntarily recalling 3,416 bottles of IBU (ibuprofen) 600 mg tablets (NDC 55111-683-05). The recall was initiated because the tablets failed to meet the required quality specifications for the medication. These products were sold in 500-count bottles and were distributed nationwide across the United States.
The tablets failed to meet established quality standards, which could potentially affect how the medication is absorbed or its overall effectiveness. No injuries or adverse events have been reported to date.
You have 2 options:
Recall #: D-0047-2025; Distributed by Dr. Reddy's Laboratories Inc., Princeton, NJ
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.